$1.235
-0.015 (-1.20%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de MTNB por análisis de gráficos similares
Alphio's MTNB stock price prediction model matches the current Matinas BioPharma Holdings Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.26 (+1.99%). The 1-week path is $1.33 (+7.87%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Matinas BioPharma Holdings Inc?
Matinas BioPharma Holdings Inc is not a good buy right now. The current price is $1.25, with an RSI of 25.709 indicating oversold conditions, but the company has reported a staggering year-to-date change of -86.56% and a negative forward P/E ratio of 0, reflecting a lack of profitability and growth potential. Additionally, the company faces delisting risk from the NYSE due to insufficient shareholder equity, which is currently at $1.8 million, below the required $2 million. This financial instability poses a significant risk for investors.
MTNB cerró en $1.24 el Monday, tras bajar -1.20%
Matinas BioPharma Holdings Inc (MTNB) last closed at $1.235, losing -1.20%. These facts feed the 1-day and 1-week MTNB price prediction above.
Consenso de analistas
Matinas BioPharma Holdings Inc (MTNB): 3 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Matinas BioPharma Holdings Inc (MTNB) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de MTNB, ordenadas por similitud.
Análisis de estacionalidad de MTNB
Historically the probability of a positive November return for MTNB is 42.22%. June offers the highest probability of a positive month at 65.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de MTNB
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $0.84 | $0.86 | $1.08 | -30.62% |
| Dec 2026 | $0.95 | $1.00 | $1.12 | -18.85% |
En 2026, se proyecta que Matinas BioPharma Holdings Inc (MTNB) oscile entre $0.84 y $1.12.
Previsión mensual de Matinas BioPharma Holdings Inc para 2026
En Nov de 2026, se proyecta que Matinas BioPharma Holdings Inc promedie $0.86, con un mínimo de $0.84 y un máximo de $1.08.
En Dec de 2026, se proyecta que Matinas BioPharma Holdings Inc promedie $1.00, con un mínimo de $0.95 y un máximo de $1.12.
Artículos relacionados
- CPI Report and the Stock Market: How to Read October 2026 Inflation Data Before the Fed DecidesOctober 2026 CPI lands Nov 10 with no year-over-year number and Fed hike odds near 80%. Learn how to read CPI, which stocks react, and how to plan for it.
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.